RLI COO granted options on 12,500 shares

RLI CORP reported that Chief Operating Officer Jennifer L. Klobnak received a grant of stock options covering 12,500 shares of RLI common stock.

Rhea-AI Filing Summary

RLI CORP reported that Chief Operating Officer Jennifer L. Klobnak received a grant of stock options covering 12,500 shares of RLI common stock. The options have an exercise price of $49.88 per share and expire on May 14, 2034. According to the award schedule, 20% of the aggregate shares become exercisable one year after the grant date and then in 20% increments each year thereafter. Following this compensation-related award, Klobnak holds 12,500 stock options directly.

Insider Trade Summary

Grant/Award: 12,500 shares

Grant/Award 1 txn

Insider Klobnak Jennifer L

Role CHIEF OPERATING OFFICER

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	12,500	$0.00	$0.00

Holdings After Transaction: Stock Option — 12,500 contracts (Direct)

Footnotes (1)

1. F1. Pursuant to option schedule wherein 20% of the aggregate number of shares granted may be exercised commencing one year from grant date and each year thereafter in 20% increments.

Key Figures

Option grant size: 12,500 shares Exercise price: $49.88 per share Expiration date: May 14, 2034 +2 more

5 metrics

Option grant size 12,500 shares Stock options covering RLI common stock

Exercise price $49.88 per share Stock option exercise price

Expiration date May 14, 2034 Option term end date

Post-grant options held 12,500 options Total options following transaction

Vesting rate 20% per year Portion of aggregate shares vesting annually

Key Terms

Stock Option, exercise price, expiration date, Grant, award, or other acquisition, +1 more

5 terms

Stock Option financial

"reported that Chief Operating Officer Jennifer L. Klobnak received a grant of stock options covering 12,500 shares"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"The options have an exercise price of $49.88 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expire on May 14, 2034"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Grant, award, or other acquisition financial

"transaction code description notes this as a Grant, award, or other acquisition"

aggregate number of shares granted financial

"20% of the aggregate number of shares granted may be exercised"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did RLI (RLI) COO Jennifer Klobnak report in this Form 4 filing?

Jennifer L. Klobnak reported receiving a grant of stock options for 12,500 RLI common shares. These options are a compensation-related award, not an open-market purchase or sale, and give her the right to buy RLI shares at a set price in the future.

How many RLI (RLI) shares are covered by Jennifer Klobnak’s new stock options?

The new stock option grant covers 12,500 shares of RLI common stock. This represents the total number of underlying shares tied to the award, all held directly by Klobnak following the reported transaction in this Form 4 filing.

What is the exercise price of Jennifer Klobnak’s RLI (RLI) stock options?

The stock options have an exercise price of $49.88 per share. This means Klobnak can purchase RLI common stock at $49.88 per share once the options vest and up until they expire, regardless of the market price at that time.

When do Jennifer Klobnak’s RLI (RLI) stock options vest and become exercisable?

The options vest in 20% increments, beginning one year after the grant date. Each year thereafter, an additional 20% of the aggregate 12,500 shares becomes exercisable, following the option schedule described in the Form 4 footnote.

What is the expiration date of Jennifer Klobnak’s RLI (RLI) stock options?

The stock options expire on May 14, 2034. After that expiration date, any unexercised options will lapse, and Klobnak will no longer have the right to purchase RLI shares under this specific grant.

Is Jennifer Klobnak’s RLI (RLI) Form 4 transaction a market buy or sell?

The Form 4 reports a grant or award acquisition of stock options, coded as an A transaction. It is a compensation-related award, not an open-market purchase or sale of RLI common stock on an exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Klobnak Jennifer L

(Last) (First) (Middle)

9025 N. LINDBERGH DRIVE

(Street)

PEORIA ILLINOIS 61615

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RLI CORP [ RLI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF OPERATING OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$49.88	05/14/2026		A		12,500		05/14/2027(1)	05/14/2034	Common Stock	12,500	$0	12,500	D

Explanation of Responses:

1. Pursuant to option schedule wherein 20% of the aggregate number of shares granted may be exercised commencing one year from grant date and each year thereafter in 20% increments.

	/s/ Jennifer L. Klobnak	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)